NASDAQ (usa) | 6715.56 | -12.11 | -0.18% | |
FTSE 100 (london) | 7487.96 | -5.12 | -0.07% | |
DAX (german) | 13465.51 | 235.94 | 1.78% | |
NIKKEI 225 (japan) | 22420.08 | 408.47 | 1.86% | |
Hang - Seng (hong kong) | 28594.06 | 348.52 | 1.23% |
NIFTY - 50 (india) | ||||
Straits Times (singapore) | 3391.61 | 17.53 | 0.52% | |
KOSPI (korea) | 2556.47 | 33.04 | 1.31% | |
All Ordinaries (australia) | 6005.30 | 28.90 | 0.48% | |
BOVESPA (brazil) | 74092.76 | -215.73 | -0.29% |
Rekah Pharmaceutical Industry Ltd (TA: REKA)
REKA Technical Analysis
4
As on 4th Feb 2025 REKA STOCK Price closed @ 1426.00 and we RECOMMEND Sell for LONG-TERM with Stoploss of 1477.84 & Strong Sell for SHORT-TERM with Stoploss of 1646.85 we also expect STOCK to react on Following IMPORTANT LEVELS. |
REKASTOCK Price
Open | 1426.00 | Change | Price | % |
High | 1426.00 | 1 Day | 74.00 | 5.47 |
Low | 1410.00 | 1 Week | 36.00 | 2.59 |
Close | 1426.00 | 1 Month | 94.00 | 7.06 |
Volume | 65 | 1 Year | -258.00 | -15.32 |
52 Week High 1788.00 | 52 Week Low 1167.00 |
TA Israel Most Active Stocks
TA125 | 2008.05 | 1.06% |
BLRX | 2.10 | -4.55% |
ORL | 106.50 | 0.47% |
BEZQ | 586.30 | 0.22% |
GODM | 95.50 | -2.35% |
CANF | 1.80 | 0.00% |
DSCT | 2657.00 | 1.96% |
ELAL | 922.00 | -2.23% |
LUMI | 4563.00 | 1.40% |
POLI | 4638.00 | 1.38% |
TA Israel Top Gainers Stocks
TA Israel Top Losers Stocks
REKA Daily Charts |
REKA Intraday Charts |
Whats New @ Bazaartrend |
REKA Free Analysis |
|
REKA Important Levels Intraday
RESISTANCE | 1456.83 |
RESISTANCE | 1446.94 |
RESISTANCE | 1440.83 |
RESISTANCE | 1434.72 |
SUPPORT | 1417.28 |
SUPPORT | 1411.17 |
SUPPORT | 1405.06 |
SUPPORT | 1395.17 |
REKA Forecast February 2025
4th UP Forecast | 2127.43 |
3rd UP Forecast | 1902.48 |
2nd UP Forecast | 1763.43 |
1st UP Forecast | 1624.38 |
1st DOWN Forecast | 1227.62 |
2nd DOWN Forecast | 1088.57 |
3rd DOWN Forecast | 949.52 |
4th DOWN Forecast | 724.57 |
REKA Weekly Forecast
4th UP Forecast | 1610.99 |
3rd UP Forecast | 1551.66 |
2nd UP Forecast | 1514.99 |
1st UP Forecast | 1478.32 |
1st DOWN Forecast | 1373.68 |
2nd DOWN Forecast | 1337.01 |
3rd DOWN Forecast | 1300.34 |
4th DOWN Forecast | 1241.01 |
REKA Forecast2025
4th UP Forecast | 2622.67 |
3rd UP Forecast | 2238.89 |
2nd UP Forecast | 2001.67 |
1st UP Forecast | 1764.45 |
1st DOWN Forecast | 1087.56 |
2nd DOWN Forecast | 850.33 |
3rd DOWN Forecast | 613.11 |
4th DOWN Forecast | 229.33 |
Rekah Pharmaceutical Industry Ltd ( TA Israel Symbol : REKA )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
REKA Other Details
Segment | EQ | |
Market Capital | 29392594944.00 | |
Sector | Healthcare | |
Industry | Drug Manufacturers-Specialty & Generic | |
Offical website | > echo $website ; ?> |
REKA Address
REKA Latest News
REKA Business Profile
Rekah Pharmaceutical Industry Ltd. engages in the manufacture, marketing, sale, and distribution of prescription and OTC drugs, dermo-cosmetics, vitamins, and nutritional supplements in Israel. The company offers steroid tablets; antibiotics, including penicillin and cephalosporin; drops and ointments to treat allergies, infections, and dryness of the eyes; dermatological preparations; baby products; and vitamins and nutritional supplements. Its portfolio of products comprise approximately 280 drugs used in various medical fields. The company was founded in 1941 and is based in Holon, Israel. Address: 30 Hamelach Street, Holon, Israel, 5881904
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service